High Content Screening Market 2019 grow at a CAGR of 10% CAGR WITH Top 10 Players as BECTON DICKINSON, BIO-RAD LABORATORIES, CELL SIGNALLING TECHNOLOGIES, DANAHER CORPORATION, GE HEALTHCARE, GENEDATA AG

The high content screening market is expected to register a CAGR of around 10%, during the forecast period, 2018 to 2023. High-content analysis (HCA) or high-content screening (HCS) defines a set of programmed diagnostic methods using integrated microscopy, image processing, and visualization gears to mine data from cells or cell populations and report quantitative results

Get your sample report now @ https://marketprognosis.com/sample-request/17053
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Technological Advancements in High Content Screening Technologies
A variety of assay technologies continue to be developed for high-content screening. These include cell-based assays, surrogate systems using microbial cells, such as yeast and bacterial two-hybrid and three-hybrid systems, and systems to measure nucleic acid-protein and receptor-ligand interactions. Modifications have been developed for cell-free, homogeneous assay systems, such as time-resolved fluorescence, fluorescence polarization, and the scintillation proximity assay. Innovations in engineering and chemistry have led to delivery systems for nanoliter volumes and sensitive biosensors for ultra-high-content screening conducted in nanoliter and picoliter volumes. Spectroscopic methods have been extended to read single-molecule fluorescence. Technologies are being developed to identify new targets from genomic information to design the next generation of screens. These advances will help drive the market in the future. Other factors, such as increase in the government funding and private investments and increase in emphasis on diagnosis will boost the market growth in the future.

Key Developments in the Market
March 2017 - Becton Dickinson, Bio-Rad Laboratories, Cell Signalling Technologies, Danaher Corporation, GE Healthcare, Genedata AG, Merck Millipore, and Perkin Elmer, among others

Major Players:
BECTON DICKINSON, BIO-RAD LABORATORIES, CELL SIGNALLING TECHNOLOGIES, DANAHER CORPORATION, GE HEALTHCARE, GENEDATA AG, MERCK MILLIPORE, PERKIN ELMER, THERMO FISHER SCIENTIFIC, AND YOKOGAWA ELECTRIC CORPORATION, amongst others.
Get Discount on this report @ https://marketprognosis.com/discount-request/17053
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Costs of Initial Investment
In case of High Content Screening, the capital required to setup up the equipment for high content screening is very expensive as there is a lot of high-end biotechnology is involved. Also, the cost of labor is very high as it requires very skilled labor, which is very expensive as the operations involved are complex and high-end laboratory professionals are often highly paid. Along with this, the lack of properly trained professionals may act as a restraining factor for the growth of high content screening market.

North America to Dominate the Market
In 2017, North America is expected to account for the largest share of the market followed by Europe. This regional segment is expected to register the highest CAGR during the forecast period. In APAC and European regions, the market is going to grow because of the increasing awareness about the efficiency of high content screening. These regions will witness considerable growth in the forecast period.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/17053
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.